Cited by 437Multiple Sclerosis Research StudiesPregnancy and Medication ImpactPsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Treatment of multiple sclerosis with the pregnancy hormone estriol

Sicotte, Nancy L., Liva, Stephanie M., Klutch, Rochelle, Pfeiffer, Paul, Bouvier, Seth, Odesa, Sylvia, Wu, T. C. Jackson, Voskuhl, Rhonda R.·2002·Annals of Neurology

DOI 10.1002/ana.10301

Open this paper in CoChat — free account

Abstract

Multiple sclerosis patients who become pregnant experience a significant decrease in relapses that may be mediated by a shift in immune responses from T helper 1 to T helper 2. Animal models of multiple sclerosis have shown that the pregnancy hormone, estriol, can ameliorate disease and can cause an immune shift. We treated nonpregnant female multiple sclerosis patients with the pregnancy hormone estriol in an attempt to recapitulate the beneficial effect of pregnancy. As compared with pretreatment baseline, relapsing remitting patients treated with oral estriol (8mg/day) demonstrated significant decreases in delayed type hypersensitivity responses to tetanus, interferon‐γ levels in peripheral blood mononuclear cells, and gadolinium enhancing lesion numbers and volumes on monthly cerebral magnetic resonance images. When estriol treatment was stopped, enhancing lesions increased to pretreatment levels. When estriol treatment was reinstituted, enhancing lesions again were significantly decreased. Based on these results, a larger, placebo‐controlled trial of estriol is warranted in women with relapsing remitting multiple sclerosis. This novel treatment strategy of using pregnancy doses of estriol in multiple sclerosis has relevance to other autoimmune diseases that also improve during pregnancy.

Integrity signals

Registry

Crossref · 10.1002/ana.10301

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
Wegmann, T. G., Lin, H., Guilbert, L., & Mosmann, T. R. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90235-d · Cited by 2,852
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.662 · Cited by 1,964
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P., & Moreau, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390501 · Cited by 1,559
Immunological Aspects Of Demyelinating Diseases
Martinꝉ, R., McFarland, H. F., & McFarlin, D. E. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.001101 · Cited by 1,021
European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis
Comi, G., Filippi, M., Wolinsky, J. S., & European/Canadian Glatiramer Acetate Study Group (2001) · Annals of Neurology · doi:10.1002/ana.64 · Cited by 768
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group.
Comi, G., Filippi, M., & Wolinsky, J. S. (2001) · PubMed · Cited by 688
Randomized controlled trial of interferon-beta-1a in secondary progressive MS
Li, D. K. B., Zhao, G., & Paty, D. W. (2001) · Neurology · doi:10.1212/wnl.56.11.1505 · Cited by 458
Glatiramer acetate (Copaxone®) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis
Duda, P. W., Schmied, M. C., Cook, S. L., Krieger, J. I., & Hafler, D. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8970 · Cited by 416
Testosterone Acts Directly on CD4+ T Lymphocytes to Increase IL-10 Production
Liva, S. M., & Voskuhl, R. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2060 · Cited by 395
Self-citation
Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis
McFarland, H. F., Frank, J. A., Albert, P. S., Smith, M. E., Martinꝉ, R., Harris, J. O., Patronas, N. J., Maloni, H. W., & McFarlin, D. E. (1992) · Annals of Neurology · doi:10.1002/ana.410320609 · Cited by 347

Show all 41 references

Sorted by citations

Items 201–300 of 437

The role of sex hormones in women with multiple sclerosis: From puberty to assisted reproductive techniques
Sparaco, M., & Bonavita, S. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100889 · Cited by 30
Estriol review: Clinical applications and potential biomedical importance
Falah, N., Torday, J. S., Quinney, S. K., & Haas, D. M. (2015) · Clinical Research and Trials · doi:10.15761/crt.1000109 · Cited by 30
Review of the effects of 17α‐estradiol in humans: a less feminizing estrogen with neuroprotective potential
Moos, W. H., Dykens, J. A., Nohynek, D., Rubinchik, E., & Howell, N. (2009) · Drug Development Research · doi:10.1002/ddr.20284 · Cited by 31
Gene microarray analysis of multiple sclerosis lesions
Lock, C., & Heller, R. A. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.10.008 · Cited by 31
Hormonal Influences in Multiple Sclerosis
Shuster, E. A. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-73677-6_11 · Cited by 29
Astragalosides from Radix Astragali benefits experimental autoimmune encephalomyelitis in C57BL /6 mice at multiple levels
He, Y., Du, M., Shi, H., Huang, F., Liu, H., Wu, H., Zhang, B., Dou, W., Wu, X., & Wang, Z. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-313 · Cited by 29
Estriol‐mediated neuroprotection in multiple sclerosis localized by voxel‐based morphometry
MacKenzie-Graham, A., Brook, J., Kurth, F., Itoh, Y., Meyer, C., Montag, M. J., Wang, H.-J., Elashoff, R., & Voskuhl, R. (2018) · Brain and Behavior · doi:10.1002/brb3.1086 · Cited by 29
Self-citation
Oral Disease-Modifying Treatments for Multiple Sclerosis
Kieseier, B. C., & Wiendl, H. (2007) · CNS Drugs · doi:10.2165/00023210-200721060-00005 · Cited by 29
Differential effects of estradiol and progesterone on human T cell activation in vitro
Papapavlou, G., Hellberg, S., Raffetseder, J., Brynhildsen, J., Gustafsson, M., Jenmalm, M. C., & Ernerudh, J. (2021) · European Journal of Immunology · doi:10.1002/eji.202049144 · Cited by 29
Sex hormones: a role in the control of multiple sclerosis?
Tomassini, V., & Pozzilli, C. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.7.857 · Cited by 28
Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment
Trojano, M., Pellegrini, F., Paolicelli, D., Fuiani, A., Zimatore, G. B., Tortorella, C., Simone, I. L., Patti, F., Ghezzi, A., Portaccio, E., et al. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.06.036 · Cited by 28
Towards a comprehensive etiopathogenetic and pathophysiological theory of multiple sclerosis
Tobore, T. O. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1677648 · Cited by 31
Estrogen and Signaling in the Cells of Immune System
Khan, D., Cowan, C., & Ahmed, S. A. (2012) · Advances in Neuroimmune Biology · doi:10.3233/nib-2012-012039 · Cited by 30
Menopause in multiple sclerosis: therapeutic considerations
Bove, R. M., Chitnis, T., & Houtchens, M. K. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7131-8 · Cited by 27
The immune system and hormones: review and relevance to pregnancy and contraception in women with MS.
Devonshire, Duquette, P., Dwosh, E., & Guimond, C. (2003) · PubMed · Cited by 27
Esclerosis múltiple, maternidad y cuestiones relacionadas con el género
Bilbao, M. D. M. M., Durán, S. B., Bárcena, J. E., & Antigüedad, A. R. (2016) · Neurología · doi:10.1016/j.nrl.2016.06.005 · Cited by 27
Combination Therapy for Multiple Sclerosis
Weinstock‐Guttman, B., & Bakshi, R. (2004) · CNS Drugs · doi:10.2165/00023210-200418120-00003 · Cited by 27
Emerging therapeutic targets in multiple sclerosis
da Fontoura, P. P., Steinman, L., & Miller, A. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000227035.93199.e0 · Cited by 27
Unique effect of the pregnancy hormone estriol on antigen-induced production of specific antibodies in female BALB/c mice
Ding, J. P., & Zhu, B. T. (2007) · Steroids · doi:10.1016/j.steroids.2007.10.012 · Cited by 26
Non-Hodgkin lymphomas in pregnancy: Tackling therapeutic quandaries
Avivi, I. M., Farbstein, D., Brenner, B., & Horowitz, N. A. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.06.004 · Cited by 26
Multiple sclerosis and pregnancy
Hughes, M. D. (2004) · Neurologic Clinics · doi:10.1016/j.ncl.2004.06.004 · Cited by 26
Sex Differences in Resting-State Functional Connectivity in Multiple Sclerosis
Koenig, K. A., Lowe, M. J., Lin, J., Sakaie, K., Stone, L., Bermel, R. A., Beall, E. B., Rao, S. M., Trapp, B. D., & Phillips, M. D. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3630 · Cited by 26
Symptoms of multiple sclerosis in women in relation to cyclical hormone changes
Holmqvist, P., Hammar, M. L., Landtblom, A., & Brynhildsen, J. (2009) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625180903137329 · Cited by 25
Sex Steroid Regulation of Microglial Cell Activation: Relevance to Multiple Sclerosis
DREW, P. D., CHAVIS, J. A., & BHATT, R. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1286.031 · Cited by 25
Offspring Number Does Not Influence Reaching the Disability’s Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study
D’Amico, E., Leone, C., & Patti, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020234 · Cited by 24
Proteomics Urine Analysis of Pregnant Women Suffering from Multiple Sclerosis
Singh, V. P., Stingl, C., Stoop, M. P., Zeneyedpour, L., Neuteboom, R. F., Smitt, P. A. E. S., Hintzen, R. Q., & Luider, T. M. (2015) · Journal of Proteome Research · doi:10.1021/pr501162w · Cited by 24
Exploring the role of sex hormones and gender diversity in multiple sclerosis
Nesbitt, C., van der Walt, A., Butzkueven, H., Cheung, A. S., & Jokubaitis, V. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01042-x · Cited by 23
Estrogen Signaling in Bystander Foxp3neg CD4+ T Cells Suppresses Cognate Th17 Differentiation in Trans and Protects from Central Nervous System Autoimmunity
Garnier, L., Laffont, S., Lélu, K., Yogev, N., Waisman, A., & Guéry, J. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800417 · Cited by 24
Cuprizone-induced demyelination in the mouse hippocampus is alleviated by phytoestrogen genistein
Ohgomori, T., & Jinno, S. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.11.009 · Cited by 24
Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosis
Eikelenboom, M. J., Killestein, J., Uitdehaag, B. M. J., & Polman, C. H. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1195oa · Cited by 23
Remyelinating and neuroprotective treatments in multiple sclerosis
Stangel, M. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.4.331 · Cited by 22
Glatiramer acetate therapy for multiple sclerosis: a review
Perumal, J. S., Filippi, M., Ford, C. C., Johnson, K. P., Lisak, R. P., Metz, L. M., Tselis, A. C., Tullman, M. J., & Khan, O. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.1019 · Cited by 22
Multiple sclerosis and pregnancy prescriptions
Coyle, P. K. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.973848 · Cited by 22
Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study
Vukusic, S., Ionescu, I., Cornu, C., Bossard, N., Durand‐Dubief, F., Cotton, F., Durelli, L., Marignier, R., Gignoux, L., Laplaud, D. A., et al. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520978218 · Cited by 21
Decreased neurofilament light chain levels in estriol‐treated multiple sclerosis
Voskuhl, R. R., Kühle, J., Siddarth, P., Itoh, N., Patel, K., & MacKenzie‐Graham, A. J. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51622 · Cited by 21
Self-citation
Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
Packer, D., Fresenko, E. E., & Harrington, E. P. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1207007 · Cited by 21
The Impact of Microbiota–Immunity–Hormone Interactions on Autoimmune Diseases and Infection
Martinelli, S., Nannini, G., Cianchi, F., Coratti, F., & Amedei, A. (2024) · Biomedicines · doi:10.3390/biomedicines12030616 · Cited by 22
Testing for the fairness and predictive validity of research funding decisions: A multilevel multiple imputation for missing data approach using ex‐ante and ex‐post peer evaluation data from the A ustrian science fund
Mutz, R., Bornmann, L., & Daniel, H. (2014) · Journal of the Association for Information Science and Technology · doi:10.1002/asi.23315 · Cited by 21
MRI activity in MS and completed pregnancy
Houtchens, M. K., Bove, R. M., Healy, B. C., Houtchens, S., Kaplan, T., Mahlanza, T. D., Chitnis, T., & Bakshi, R. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000890 · Cited by 21
CCR5-Δ32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis
Kaimen-Maciel, D. R., Reiche, E. M. V., Brum, D. G., Comini, E. F., Rocha, F. H., Morimoto, H. K., Watanabe, M. E., de Oliveira, J. C., Matsuo, T., Lopes, J. M., et al. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.3.337 · Cited by 21
Sclérose en plaques et grossesse
Vukusic, S., & Confavreux, C. (2006) · Revue Neurologique · doi:10.1016/s0035-3787(06)75016-0 · Cited by 21
A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis
Collongues, N., Becker, G., Jolivel, V., Ayme‐Dietrich, E., Seze, J. D., Binamé, F., Patte‐Mensah, C., Monassier, L., & Mensah‐Nyagan, A. G. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00363-7 · Cited by 22
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis
Landi, D., Ragonese, P., Prosperini, L., Nociti, V., Haggiag, S., Cortese, A., Fantozzi, R., Pontecorvo, S., Ferraro, E., Buscarinu, M. C., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318468 · Cited by 20
Pregnancy-Induced Changes in microRNA Expression in Multiple Sclerosis
Søndergaard, H. B., Airas, L. M., Christensen, J. R., Nielsen, B. R., Börnsen, L. S., Oturai, A. B., & Sellebjerg, F. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.552101 · Cited by 21
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies
Broadley, S., Barnett, M. H., Boggild, M., Brew, B. J., Butzkueven, H., Heard, R. N., Hodgkinson, S. J., Kermode, A. G., Lechner‐Scott, J., Macdonell, R. A. L., et al. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2014.01.016 · Cited by 24
17β-Estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis.
Kashani, I. R., Hedayatpour, A., Pasbakhsh, P., Kafami, L., Atlasi, N., Mahabadi, V. P., Mamoudi, R., & Baazm, M. (2012) · PubMed · Cited by 19
Reactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism
Jackson, D. J., Murphy, M., SOOTHILL, P. W., Lucas, G., Elson, C. J., & Kumpel, B. M. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02903.x · Cited by 19
Nuclear hormone receptors in demyelinating diseases
Zorrilla-Veloz, R. I., McKenzie, T., Palacios, B. E., & HU, J. L. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13171 · Cited by 19
The impact of menopause on multiple sclerosis
Bridge, F., Butzkueven, H., van der Walt, A., & Jokubaitis, V. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103363 · Cited by 17
The Influence of Sex Hormones and X Chromosome in Immune Responses
Anesi, N., Miquel, C., Laffont, S., & Guéry, J. (2023) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-35139-6_2 · Cited by 20
Sex-Specific Environmental Impacts on Initiation and Progression of Multiple Sclerosis
Leffler, J., Trend, S., Gorman, S., & Hart, P. H. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.835162 · Cited by 19
Targeting Estrogen Signaling in the Radiation-induced Neurodegeneration: A Possible Role of Phytoestrogens
Mitra, S., Dash, R., Sohel, M., Chowdhury, A., Munni, Y. A., Ali, M. C., Hannan, M. A., Islam, T., & Moon, I. S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220310115004 · Cited by 19
Future treatment approaches to multiple sclerosis
Derwenskus, J., & LUBLIN, F. D. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00024-8 · Cited by 17
Development of gray matter atrophy in relapsing–remitting multiple sclerosis is not gender dependent: Results of a 5-year follow-up study
Doležal, O., Gabelić, T., Horáková, D., Bergsland, N., Dwyer, M. G., Seidl, Z., Krásenský, J., Ramasamy, D. P., Vaněčková, M., Havrdová, E., et al. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.09.020 · Cited by 17
Effects of sex hormones on costimulatory molecule expression in multiple sclerosis
Pelfrey, C. M., Moldovan, I. R., Cotleur, A. C., Zamor, N., & Rudick, R. A. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.06.014 · Cited by 17
Chemokine network in multiple sclerosis: role in pathogenesis and targeting for future treatments
Galimberti, D., Bresolin, N., & Scarpini, E. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.3.439 · Cited by 18
Retinal optical coherence tomography measures in multiple sclerosis: a systematic review and meta‐analysis
Ayoubi, N. K. E., Ismail, A., Fahd, F., Younes, L., Chakra, N. A., & Khoury, S. J. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52165 · Cited by 18
Bioidentical hormones: an evidence-based review for primary care providers.
Conaway, E. M. (2011) · PubMed · Cited by 16
Estriol in regulation of cell-mediated immune reactions in multiple sclerosis
Некрасова, И. В., & Ширшев, С. В. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577421 · Cited by 16
Gender issues
Coyle, P. K. (2005) · Neurologic Clinics · doi:10.1016/j.ncl.2004.10.003 · Cited by 16
Neuroprotection in Cerebral Cortex Induced by the Pregnancy Hormone Estriol
Meyer, C., Smith, A. W. T., Requerey, A. P., Farkhondeh, V., Itoh, N., Itoh, Y., Gao, J. L., Herbig, P. D., Nguyen, Q., Ngo, K. H., et al. (2023) · Laboratory Investigation · doi:10.1016/j.labinv.2023.100189 · Cited by 14
Self-citation
Role of Magnetic Resonance Imaging and Immunotherapy in Treating Multiple Sclerosis
Zhang, J., & Hutton, G. J. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104739 · Cited by 15
New insights into an old story
Speranza, A., & Scoccianti, V. (2012) · Plant Signaling & Behavior · doi:10.4161/psb.20674 · Cited by 15
Gender Issues in Multiple Sclerosis
Giesser, B. S. (2002) · The Neurologist · doi:10.1097/00127893-200211000-00003 · Cited by 15
Symptoms of multiple sclerosis during use of combined hormonal contraception
Kempe, P., Hammar, M. L., & Brynhildsen, J. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.06.030 · Cited by 14
Serum leptin levels during pregnancy in multiple sclerosis
Neuteboom, R. F., Verbraak, E., Voerman, J., van Meurs, M., Steegers, E., de Groot, C. J. M., Laman, J., & Hintzen, R. Q. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509106515 · Cited by 14
Multiple sclerosis management and reproductive changes
Kaisey, M., Sicotte, N. L., & Giesser, B. S. (2018) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000436 · Cited by 14
Self-citation
Effect of hormonal changes on the neurological status in the menstrual cycle of patient with multiple sclerosis
Yorgun, Y. G., & Özakbaş, S. (2019) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2019.105499 · Cited by 14
GPR30 Forms an Integral Part of E2-Protective Pathway in Experimental Autoimmune Encephalomyelitis
Bodhankar, S., & Offner, H. (2011) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/1871522211108040262 · Cited by 14
Emerging therapies in multiple sclerosis
Farrell, R. A., Heaney, D. C., & Giovannoni, G. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.4.797 · Cited by 14
The association of menopausal hormone levels with progression-related biomarkers in multiple sclerosis
Juutinen, L., Ahinko, K., Hagman, S., Basnyat, P., Jääskeläinen, O., Herukka, S., & Sumelahti, M. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105517 · Cited by 15
Diffusion tensor imaging identifies aspects of therapeutic estrogen receptor β ligand-induced remyelination in a mouse model of multiple sclerosis
Atkinson, K. C., Lee, J. B., Hasselmann, J., Kim, S. H., Drew, A., Soto, J. S., Katzenellenbogen, J. A., Harris, N. G., Obenaus, A., & Tiwari-Woodruff, S. K. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104501 · Cited by 13
Improvement of Remyelination in Demyelinated Corpus Callosum Using Human Adipose-Derived Stem Cells (hADSCs) and Pregnenolone in the Cuprizone Rat Model of Multiple Sclerosis
Ganji, R., Razavi, S., Ghasemi, N., & Mardani, M. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01515-w · Cited by 13
Multiple sclerosis: pregnancy and women's health issues
Bilbao, M. D. M. M., Durán, S. B., Bárcena, J. E., & Antigüedad, A. R. (2018) · Neurología (English Edition) · doi:10.1016/j.nrleng.2016.06.014 · Cited by 13
Rapid, nongenomic signaling effects of several xenoestrogens involved in early- vs. late-stage prostate cancer cell proliferation
Koong, L. Y., & Watson, C. S. (2015) · Endocrine Disruptors · doi:10.4161/23273747.2014.995003 · Cited by 13
Testosterone and Myelin Regeneration in the Central Nervous System
Schumacher, M., Ghoumari, A. M., Mattern, C., Bougneres, P. F., & Traiffort, É. (2021) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0023 · Cited by 14
17β-Estradiol and 17α-estradiol induce rapid changes in cytoskeletal organization in cultured oligodendrocytes
Hirahara, Y., Matsuda, K., Liu, Y. F., Yamada, H., Kawata, M., & Boggs, J. M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.070 · Cited by 12
Application of Bioassays/Biosensors for the Analysis of Pharmaceuticals in Environmental Samples
Valera, E., Babington, R., Broto, M., Petanas, S., Galvé, R., & Marco, M. ‐. (2013) · Comprehensive analytical chemistry · doi:10.1016/b978-0-444-62657-8.00007-0 · Cited by 12
Current trends in multiple sclerosis research: an update on pathogenic concepts.
Vanderlocht, J., Hellings, N., Hendriks, J. J. A., & Stinissen, P. (2006) · PubMed · Cited by 11
The role of neuroactive steroids in psychiatric and neurological disorders: Neurobiology and therapeutic perspectives
Pinna, G., & Bortolato, M. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106438 · Cited by 12
Reproductive Issues in MS
Kaplan, T., & Houtchens, M. K. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1608925 · Cited by 11
Hormone and immune system interactions in demyelinating disease
Gomez, F. P., Steelman, A. J., Young, C. R., & Welsh, C. J. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.10.014 · Cited by 11
Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions
Rosler, E. S., Lariosa-Willingham, K. D., Tung, J. S., Dugas, J. C., Collins, T. L., & Leonoudakis, D. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2219-8 · Cited by 11
Experimental solubility of diosgenin and estriol in various solvents between T= (293.2–328.2) K
Moodley, K., Rarey, J., & Ramjugernath, D. (2016) · The Journal of Chemical Thermodynamics · doi:10.1016/j.jct.2016.11.017 · Cited by 11
Continuing Education
Carter, B. L., Rodby, R. A., Orland, B. I., Lewis, S. J., & Hunsicker, L. G. (2004) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2004.10.s5-a.s26 · Cited by 11
Gender Hormones: Role in the Pathogenesis of Central Nervous System Disease and Demyelination
Voumvourakis, K. I., Tsiodras, S., Kitsos, D. K., & Stamboulis, E. (2008) · Current Neurovascular Research · doi:10.2174/156720208786413398 · Cited by 11
Mechanisms of multiple sclerosis
Lassmann, H. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.11.007 · Cited by 14
Sex hormones and multiple sclerosis: another informative failure
Langer-Gould, A. M. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00348-8 · Cited by 10
Sex Differences in Neurological Diseases
Sohrabji, F., Welsh, C. J., & Reddy, D. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802114-9.00012-3 · Cited by 10
Immune profile in relation to sex steroid cyclicity in healthy women and women with multiple sclerosis
Kempe, P., Eklund, D., Hallin, A., Hammar, M. L., Olsson, T. P., Brynhildsen, J., & Ernerudh, J. (2018) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2018.02.006 · Cited by 10
The role of puberty and adolescence in the pathobiology of pediatric multiple sclerosis
Salpietro, V., Polizzi, A., Recca, G., & Ruggieri, M. (2018) · Multiple Sclerosis and Demyelinating Disorders · doi:10.1186/s40893-017-0032-4 · Cited by 10
The protective role of breastfeeding in multiple sclerosis: Latest evidence and practical considerations
Collorone, S., Kodali, S., & Toosy, A. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1090133 · Cited by 10
Estriol and Progesterone: A New Role for Sex Hormones
Drača, S., Zotovic", D. M., & S. 1. (2006) · International Journal of Biomedical Science · doi:10.59566/ijbs.2006.2305 · Cited by 10
Pregnancy Is Associated with Impaired Transcription of Human Endogenous Retroviruses and of TRIM28 and SETDB1, Particularly in Mothers Affected by Multiple Sclerosis
Tovo, P., Marozio, L., Abbona, G., Calvi, C., Frezet, F., Gambarino, S., Dini, M., Benedetto, C., Galliano, I., & Bergallo, M. (2023) · Viruses · doi:10.3390/v15030710 · Cited by 9
The future of multiple sclerosis treatment
Cohen, J. A. (2009) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(09)70015-2 · Cited by 9
SEX DIFFERENCES IN MULTIPLE SCLEROSIS
Crabtree‐Hartman, E. (2010) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000389942.81981.72 · Cited by 9
17α‐estradiol: a less‐feminizing estrogen
Moos, W. H., Dykens, J. A., & Howell, N. (2008) · Drug Development Research · doi:10.1002/ddr.20244 · Cited by 10
Sex Disparities in Neuro-Ophthalmologic Disorders
Chen, J. J.-W., Costello, F., & Kardon, R. H. (2014) · Current Eye Research · doi:10.3109/02713683.2014.922195 · Cited by 9
Matrix Metalloproteinases, Synaptic Injury, and Multiple Sclerosis
Szklarczyk, A., & Conant, K. E. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00130 · Cited by 9
Sex-Related Differences in Lifestyle Factors Affecting Multiple Sclerosis Susceptibility and Disease Progression
Barbuti, E., Piervincenzi, C., Ruggieri, S., & Petracca, M. (2025) · Brain Sciences · doi:10.3390/brainsci15101097 · Cited by 9

Authors: Sicotte, N. L., Liva, S. M., Klutch, R., Pfeiffer, P., Bouvier, S., Odesa, S., Wu, T. C. J., & Voskuhl, R. R.
Affiliations: University of California, Los Angeles (US)
Corresponding author: Voskuhl, Rhonda R.
ORCID: Sicotte, Nancy L.
Voskuhl, Rhonda R.
Venue: Annals of Neurology
Publisher: Wiley
Published: 2002-08-19
Volume: 52
Issue: 4
Pages: 421-428
ISSN: 0364-5134 (ISSN-L)
1531-8249
DOI: 10.1002/ana.10301
OpenAlex: W2135551891
Cited by: 435
References: 41
Citations by year: 2026: 7 · 2025: 8 · 2024: 10 · 2023: 13 · 2022: 13 · 2021: 9 · 2020: 14 · 2019: 12 · 2018: 22 · 2017: 11 · 2016: 24 · 2015: 19 · 2014: 30 · 2013: 25 · 2012: 30
FWCI: 12.95
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Annals of Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: multiple sclerosis, estriol, pregnancy hormones, relapsing-remitting multiple sclerosis, interferon-gamma, delayed-type hypersensitivity, gadolinium-enhancing lesions, disease-modifying therapy
MeSH terms: Adolescent, Adult, Estriol, Female, Humans, Hypersensitivity, Delayed, Magnetic Resonance Imaging, Middle Aged, Multiple Sclerosis, Pregnancy, Recurrence, Biomarkers, Th1 Cells, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Treatment of multiple sclerosis with the pregnancy hormone estriol

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks